Saving the patient with post-ACS cardiogenic shock

Area of Science:

• Cardiology
• Critical Care Medicine

Background:

• Early revascularization significantly reduced post-acute coronary syndrome (ACS) cardiogenic shock (CS).
• However, CS incidence upon hospital arrival and in-hospital/30-day mortality remain high, especially in facilities with revascularization capabilities.
• Existing trials on intra-aortic counter-pulsation (IACP) and advanced mechanical circulatory support (MCS) have not shown significant mortality reduction.

Purpose of the Study:

• To address the persistent high mortality in post-ACS CS.
• To propose a novel classification system for better patient characterization and therapeutic goal definition.
• To highlight the need for deeper understanding of CS pathophysiology.

Main Methods:

• Review of current strategies and trial outcomes for STEMI and high-risk ACS.
• Analysis of mortality data and factors influencing outcomes in CS patients.
• Proposal of the "Guthrie classification" for post-ACS CS.

Main Results:

• Mortality for CS remains high at 45-60%, influenced by patient characteristics, revascularization success, and MCS.
• Most CS survivors achieve satisfactory functional capacity and quality of life.
• The proposed Guthrie classification aims to improve patient stratification in clinical trials and registries.

Conclusions:

• Despite advances, post-ACS CS remains a critical challenge with high mortality.
• Timely revascularization and advanced MCS are crucial but insufficient for universal mortality reduction.
• Further research into the biochemical and cellular mechanisms of CS is essential for fundamental outcome improvements.